This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): long-acting basal insulin
Description: FT-105 is a long-acting recombinant insulin formulation that uses a microparticulate adaptation of Flamel’s proprietary Medusa nanoparticle delivery system. FT-105 comprises lyophilised microparticles of Medusa nanopolymers embedded with recombinant human insulin.
Pink Sheet Weekly Trademark Review Dec. 27, 2016
Pink Sheet What’s Yet To Come From Insulin Pipeline
Pink Sheet Weekly Trademark Review Nov. 3, 2015
Additional information available to subscribers only: